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Proteomic Identification Reveals the Role of Ciliary
Extracellular-Like Vesicle in Cardiovascular Function
Ashraf M. Mohieldin, Rajasekharreddy Pala, Rinzhin T. Sherpa, Madhawi Alanazi,
Ashwaq Alanazi, Kiumars Shamloo, Amir Ahsan, Wissam A. AbouAlaiwi,
James J. Moresco, John R. Yates III, and Surya M. Nauli*
Primary cilia are shown to have membrane swelling, also known as ciliary
bulbs. However, the role of these structures and their physiological relevance
remains unknown. Here, it is reported that a ciliary bulb has extracellular
vesicle (EV)-like characteristics. The ciliary extracellular-like vesicle (cELV) has
a unique dynamic movement and can be released by mechanical fluid force.
To better identify the cELV, differential multidimensional proteomic analyses
are performed on the cELV. A database of 172 cELV proteins is generated, and
all that examined are confirmed to be in the cELV. Repressing the expression
of these proteins in vitro and in vivo inhibits cELV formation. In addition to
the randomized heart looping, hydrocephalus, and cystic kidney in fish,
compensated heart contractility is observed in both fish and mouse models.
Specifically, low circulation of cELV results in hypotension with compensated
heart function, left ventricular hypertrophy, cardiac fibrosis, and
arrhythmogenic characteristics, which result in a high mortality rate in mice.
Furthermore, the overall ejection fraction, stroke volume, and cardiac output
are significantly decreased in mice lacking cELV. It is thus proposed that the
cELV as a nanocompartment within a primary cilium plays an important role
in cardiovascular functions.
1. Introduction
Primary cilia exist on almost all mammalian cell types. Cilia have
been hypothesized to act as mechanosensory and chemosensory
organelles.[1,2] The ciliary membrane houses many receptors, ion
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channels, transporters, and other sensory
proteins to support distinctive functions
of cilia. The cilioplasm is also enriched
with many signaling proteins. Any mal-
functioning of ciliary signaling and pro-
tein transport to cilia, which are required
to coordinate a key role in cilia assem-
bly and function, can result in a wide
range of diseases, termed ciliopathies.
Since cilia are ubiquitous, ciliopathies in-
clude a wide spectrum of phenotypes as
seen in Joubert syndrome,[3–5] Bardet–Biedl
syndrome,[6,7] polycystic kidney disease,[8,9]
Meckel–Gruber syndrome,[10,11] and many
others.
To better understand the roles of pri-
mary cilia, many studies have investigated
the structure and the complexity of ciliary
proteomes. To date, cilia proteome has re-
vealed hundreds of crucial proteins rele-
vant to cilia formation and ciliopathy.[12–15]
However, these proteins have not been
studied within the subdomain of ciliary
membrane. Structurally, a primary cil-
ium has a protruding vesicle-like structure
along the cilia, commonly referred to ciliary bulb. First observed
in 1977,[16] ciliary bulb has since been proposed to be an artifact
resulting from changes in osmotic pressure during fixation.[17–19]
Many interesting studies have also emerged associating the
shedding of ciliary proteins in membrane-bound vesicles.[20–22]
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While the release of these ciliary proteins regulates ciliary
signaling for normal male mating behaviors in Caenorhabdi-
tis elegans,[23] it also occurs when cells underwent flagellar
resorption.[24] It is recently proposed that ciliary membrane is
also shredded in pathological contexts when a protein complex
known as BBSome fails to retrieve from cilium to cell body.[25]
The complexity of the ciliary membrane shredding is further in-
trigued by a study showing that the release of ciliary membrane
can occur freely as a normal process to regulate cilia length.[26]
Importantly, the impact of this shredding on the cilia function
and ciliopathy is still unknown. Further, the proteome within this
shredding is largely unidentified. At least in C. elegans, glutamy-
lases and deglutamylases are required for ciliary shredding.[27,28]
While ciliary glutamination may control the shredding in C. el-
egans, the initial environmental signals or the mechanisms that
regulate activities of glutamination enzymes within a cilium are
yet to be studied in the mammalian system.
Although ciliary membrane shredding has never been impli-
cated in cardiovascular function, many extracellular membrane
vesicles from the cell body have been thought to function as in-
tracardiac communication for horizontal transfer of information
within cardiovascular cells.[29] Importantly, vascular endothelia
and cardiomyocytes secrete microvesicles,[30,31] which have been
proposed to indicate cardiovascular functions.[32] The commu-
nication functions of these microvesicles have been eluded to
play a role in angiogenesis, cardiac remodeling, and fibrosis with
cardioprotective and atherosclerotic-protective properties.[30,31,33]
For examples, high levels of circulating microvesicles with pro-
coagulant potential are found in patients with acute coronary
syndromes.[34] While there is no clear consensus on different mi-
croenvironment that dictates communication via microvesicles
versus autocrine, paracrine or endocrine routes, it is believed that
microvesicles provide a better regulated and more protected cell–
cell communication on complex different microenvironmental
signals for cellular uptake within the cardiovascular system.
Although ciliary function or signaling has been implicated in
human ciliopathies, not much has been studied with regards to
microstructure of ciliary shaft. Further, to observe and study these
ciliary vesicles in real time is very challenging if not impossible in
monolayer setup. Most laboratories depend on the fluorescence
imaging to see the shredding of primary cilia. Using a single-
cell–single-cilium imaging technique allowed us to examine cilia
structure without the need of fluorescence. We identified that the
extracellular vesicle (EV) released from nonciliated cells is func-
tionally different from ciliary extracellular-like vesicle (cELV). We
used unbiased differential proteomic approach to characterize
the physiological relevance of this cELV. Our study showed that
cELV is a specific microdomain of the primary cilium, and it may
play an important physiological role in cardiovascular functions.
2. Results
2.1. The cELV Is a Subdomain of Ciliary Membrane and
Mechanically Regulated by Fluid Shear Stress
Examining a single cell from the side, we studied the protrud-
ing structure (cELV) within the primary cilia (Figure S1a–c,
Supporting Information). Because cilia are mechanosensory
organelles,[35] we used a low shear force (0.3 dyn cm−2) that would
not significantly bend the cilium and a high shear force (1 dyn
cm−2) that would bend the cilium over 45°. The perimeter and
circularity of the cELV were greatly altered during cilium bend-
ing by high shear stress, suggesting a potential role for mechani-
cal shear force on the cELV. The cELV moved up and down along
the cilium during static conditions, but it failed to reach to the
tip of the cilium (Movie S1, Supporting Information). In some
cases, multiple cELV was clearly distinguished at the tip of the
cilium during bending, due to shear flow (Movie S2, Supporting
Information). Based on our mathematical modeling, the flexu-
ral rigidity of cilia was double in the present than in the absent of
cELV (Supplement S1, Supporting Information), and the mass of
the cELV directly correlated with the mass of primary cilia (Sup-
plement S2, Supporting Information).
Because our initial studies indicated a potential role for me-
chanical fluid force on the cELV, we hypothesized that the cELV
could be released from the cilia by fluid-shear stress. First, we
examined if the cELV had similar characteristics to the already
known extracellular vesicle (EV). Like EV,[36–38] the cELV for-
mation could be inhibited by ceramide-mediated vesicle block-
ers (Figure S1d–g, Supporting Information). These inhibitors
did not affect cilia formation or cell division. In all our stud-
ies, cilia length was examined in three dimensions, utilizing the
single-cell–single-cilium technique (Movie S3, Supporting Infor-
mation). We also found that the cELV formation was depended
on kinesin but not dynein.
Second, we examined the cELV formation with the EV marker
CD63-GFP[39] (Figure S2a–c, Supporting Information). CD63-
GFP was expressed throughout the cell body and cilia in the
first 24 h post-transfection and specifically in the cELV at 72 h
post-transfection (Figure 1a; Movie S4, Supporting Information).
This further solidified the idea that cELV and EV shared similar
characteristics.
Third, we examined the release of cELV in the absence and
presence of fluid flow in ciliated wild-type and nonciliated Tg737
cells. Our results indicated that while cilia were not required to re-
lease basal level of vesicles, fluid flow might induce the release of
cELV from primary cilia (Figure 1b). To confirm that cELVs were
released from cilia, we performed several experiments in the ab-
sence and presence of fluid flow (Movie S4, Supporting Informa-
tion). In all cases, fluid-shear stress caused the release of cELV.
Forth, we examined the structure and function of cELV. After
carefully standardized the cELV containing CD63-GFP (Figure
S1d–g, Supporting Information), we isolated and examined them
with scanning electron microscopy (Figure 1c). The cELV had a
round shape with a diameter of 237 ± 7 nm. We also verified
the purity of the isolation method by immunoblotting for CD63
and HSP70 (positive controls) and Golgin-97 (negative control)
(Figure 1d), confirming the purity of the cELV isolation.[40,41] Us-
ing the same isolation method, we showed that exogenous cELV
could trigger cellular signaling in the cilioplasm and cytoplasm
(Figures S3–S7 and Movies S5–S7, Supporting Information).
2.2. A MudPIT Proteomic Analysis Reveals Novel cELV Proteins
To further analyze the functions of cELV in cell signaling, we used
a comprehensive and unbiased strategy that included proteomic
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studies followed by in vivo validation. To evaluate the protein
composition of cELV, we first isolated primary cilia containing
ELV to distinguish cELV from other EV because the cell body re-
leases EV into the extracellular media.[25,38] The cELV formation
can be induced by mechanical fluid force;[42] therefore, we iso-
lated the primary cilia containing cELV by mechanical fluid force
(see Methods and Movie S8, Supporting Information). Isolated
cilia were thoroughly validated in multiple independent prepara-
tions (Figure S8, Supporting Information).
Second, the isolated cilia and whole-cell lysates were then sub-
jected to proteomic analysis using a sensitive multidimensional
protein identification technology (MudPIT) technique.[43] A
standard MudPIT analysis (Figure S8, Supporting Information)
and a more stringent MudPIT microanalysis (Figure 1e) were
used and compared our proteomic data in order to increase our
experimental rigor. Both MudPIT analyses consistently indicated
that 2% of the total organellar protein fragments were localized
in the cilia (Table S1, Supporting Information). However, the en-
tire proteome was potential candidates of cELV-derived proteins,
including the organellar proteins that were previously known as
ciliary proteins.
Third, we set our inclusion criterion based on the protein spec-
tral count that depicted close-to-zero protein fragments in the
whole cells but showed an abundance in the isolated cilia. We also
included those protein fragments that were present at a two-fold
or higher ratio in cilia lysates than cell lysates (cilia-to-cell ratio ≥
2). These criteria decreased the total number of potential candi-
dates of cELV proteins to 211 (Table S2, Supporting Information);
172 of these proteins had never been reported in primary cilia.
Of the 172 proteins, there were 25 proteins that consistently ap-
peared in spectral counts of cilia lysates (Figure 1f). Further, 6.4%
of the proteins were known to be EV biomarker proteins.
Forth, to validate the proteomic studies, we selected five mem-
brane proteins (BMPR2, TfR1, JAM-A, PTPRS, and PGRMC2)
from these 25 proteins. Our selection was based on the fact that
these proteins are membrane proteins, which may have a signif-
icant function in chemosensory functions of cilia. To examine
the functions of these proteins, the expression of BMPR2, TfR1,
JAM-A, PTPRS, and PGRMC2 in isolated primary cilia were con-
firmed (Figure 1g).
2.3. Newly Identified Proteins Are Required for cELV Formation
and Cellular Functions
We next took several approaches to investigate the functions of
BMPR2, TfR1, JAM-A, PTPRS, and PGRMC2. First, we con-
firmed that the subcellular localization of these proteins was ob-
served in the cELV (Figure 2). Because of the microenvironment
sensitivity of cELV to shear stress and the conditions of the im-
munostaining technique requiring a series of washing steps fol-
lowed by fixation, all cELV were consequentially seen at the tip of
the cilium. The size of the cELV at the tip of the cilia was not re-
flective of the actual size of a single cELV, as in many cases cELV
could aggregate together, especially during shear-stress.
Second, we generated stable knockdown cells for each of the
five corresponding genes (Figure S9, Supporting Information).
For each knockdown, we used four potential sequences to select
the sequence with the highest knockdown efficiency (see Meth-
ods in the Supporting Information). The formation of cilia and
cELV were measured and quantified in these stable knockdown
cells (Figure 3a). BMPR2, PTPRS, and PGRMC2 were involved in
cilia formation (Figure 3b). Even when cilia were present in these
cells, the formation of cELV was significantly abolished in all five
(BMPR2, TFRC, F11R, PTPRS, and PGRMC2) knockdown cells
(Figure 3c). The BMPR2 knockdown cells did not form cELV
at all; F11R knockdown cells, when cELV did form, had much
smaller cELV than the control cells. When the cilium length
was tabulated, it showed that cilia were significantly longer in
BMPR2, TFRC, and F11R knockdown cells than in the scrambled
control cells (Figure 3d). Although BMPR2 knockdown cells had
significantly fewer cilia formation than the control cells, BMPR2
knockdown cells had longer cilia when cilia were ever formed.
Third, we examined cellular proliferation and migration in sta-
ble knockdown cells (Figure S10, Supporting Information). Ex-
cept for the PTPRS cells, which had a lower proliferation index,
the proliferation indices for the rest of knockdown cells were in-
creased when compared with the scrambled control cells. Com-
pared with the control cells, all the knockdown cells exhibited a
significant impairment in migration. Perhaps, the abnormal pro-
liferation and migration, which were associated with cELV, were
not surprising, given the roles of primary cilia in cell proliferation
and migration.[44,45]
Forth, to examine the relationship between the five-selected
proteins with each other and with other possible ciliopathy and
EV proteins, we constructed a protein–protein interaction net-
work from our proteomic database (Figure 3e). Interestingly,
TFRC a known EV marker[46] appeared in the network interac-
tion. Likewise, other known EV markers (CAV1 and Ywhae) were
also noted in the interaction network beside TMEM216.[47,48] Fur-
thermore, while all five genes directly or indirectly interacted with
each other and TMEM216, a gene responsible for Joubert syn-
drome and Meckel–Gruber syndrome ciliopathy disorders,[3–5]
Figure 1. Proteomic identification of cELV proteins. a) CD63-GFP was localized in the cELV (arrow; Movie S4, Supporting Information). The cELV can
be seen in the differential interference contrast (DIC) image. CD63-GFP localization to cELV at different time points is shown in Figure S2c (Supporting
Information). b) Fluid shear stress (1 dyn cm−2 for 30 min) induced the release of cELV in cells with cilia (wild-type) but not in those without cilia (Tg737).
The release of the cELV from a cilium can be seen in Movie S4 (Supporting Information). c) After fluid flow, CD63-GFP vesicles were isolated from the
eluent. A scanning electron microscopy (SEM) image of a single CD63-GFP vesicle is shown. Isolation and purification are shown in Figure S2 (Supporting
Information). d) Purity of CD63-GFP vesicles was further verified by immunoblotting for CD63 and HSP70 (positive controls) and Golgin-97 (negative
control). e) Based on the micro MudPIT separation, a comparative proteomic analysis between isolated primary cilia (with induced cELV appearance) and
whole cell lysates, indicated that 2% of all organellar proteins were localized within the cilia (and cELV). About 18.5% of all these cELV proteins have been
previously confirmed to be in the cilia (Table S2, Supporting Information). Proteomic analysis using a standard MudPIT separation was also performed
(Figure S8f, Supporting Information). f) A representative heat-map image shows the newly identified ciliary proteins that consistently appeared in all
MudPIT samples. The relative abundance of each protein is indicated in orange (high abundance; samples 1 and 2) and blue (low abundance; samples
3, 4, and 5). g) A western blot analysis confirmed the expression of all five selected ciliary proteins. Acetylated 𝛼-tubulin and actin were used as controls
to indicate the purity of isolated cilia. N = 3 in each group. ***, p < 0.001.
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TMEM216 interacted directly with F11R and PGRMC2 in the net-
work interaction model. To validate this network model, we fur-
ther investigated the interaction between these three proteins.
TMEM216 expression was significantly repressed in F11R and
PGRMC2 knockdown cells (Figure 3f,g).
Fifth, to identify the expression of TMEM216, F11R, and
PGRMC2 in cELV, we validated the expression of the exosomal
marker CD63. There was a strong expression of TMEM216 in
the isolated cELV from the control cells but not from the knock-
down cells. We also reverified our cELV isolation from CD63-
cELV. These results indicate that cELV release was impeded in
the knockdown cells. Importantly, the total number of cELV col-
lected from cell media was significantly decreased (Figure 3h).
2.4. Repressing cELV Protein Expression Results in Cystic Kidney,
Hydrocephalus, Situs Inversus, and Cardiac Edema
To understand the in vivo relevance of these BMPR2, TfR1, JAM-
A, PTPRS, and PGRMC2 proteins, we first used zebrafish as a
model to screen the phenotypes associated with abnormal cELV
formation (Figure S12, Supporting Information). Because ze-
brafish has two isoforms (spice variants) of BMPR2, we exam-
ined the role of each variant (BMPR2A and BMPR2B). In these
studies, scrambled and Pkd2 knockdown were used as nega-
tive and positive controls, respectively. Although some variation
and severity were observed, knockdown of the corresponding six
genes (BMPR2A, BMPR2B, TFRC, F11R, PTPRS, and PGRMC2)
resulted predominantly in ciliopathic disorders, including ab-
normal development, hydrocephalus, kidney cysts, and left–right
asymmetry in cardiac looping (Movies S9 and S10, Supporting
Information).
Based on the protein interaction network interaction with
TMEM216, F11R, and PGRMC2 fish were selected for a more
in-depth analysis. The abnormal development of F11R and
PGRMC2 knockdown fish was indicated by either a strong
dorsal axis curvature or incomplete development of the dor-
sal axis (Figure 4a). Hydrocephalus and renal cysts were ob-
served in the knockdown fish. The left–right asymmetry in
cardiac looping was more apparent in PGRMC2 than F11R
fish (Figure 4b). The knockdown was rescued by introduc-
ing the corresponding human PGRMC2 or human F11R into
the fish. The expression of PGRMC2 or F11R was confirmed
(Figure 4c). The phenotypes from the corresponding knockdown
fish were rescued by the expression of human PGRMC2 or F11R
(Figure 4d).
Pericardial edema was also observed in the majority of the
knockdown fish, suggesting a potential cardiovascular abnormal-
ity. To investigate this possibility, we measured the main pa-
rameters of heart function (Movies S11 and S12, Supporting
Information). We quantified heart rate and contractility in the
knockdown and rescued fish (Figure 5a). In F11R fish, cardiac
contractility was decreased with an increased diastolic volume
(Figure 5b). The data indicated that the F11R hearts were fail-
ing, and they were potentially compensated by an increase in
preload (diastolic volume) to support normal stroke volume.
In PGRMC2 fish, heart rate was significantly increased, re-
sulting in a marked increase in cardiac output. Interestingly,
while the heart contractility was not significantly increased in
PGRMC2 fish, the systolic and diastolic volumes were markedly
increased, resulting in a significant increase in stroke volume.
The data indicated that the PGRMC2 hearts were stimulated
by the sympathetic innervation (increase heart rate), poten-
tially to compensate for the weak cardiac contractility, i.e., af-
ter sympathetic stimulation, heart contractility was not changed
while stroke volume increased through an increase in preload.
Overall, the fish data indicated that from F11R and PGRMC2
fish had failing hearts and were compensated by an increased
in preload.
2.5. Mice Lacking cELV Are Characterized by Hypotension
To validate zebrafish data, we used a lentivirus strategy to deliver
PGRMC2 or F11R-targeted shRNA into 2 week old mice (Fig-
ure 6a). The lentivirus infection was first verified using non-GFP
scrambled and GFP-tagged PGRMC2 or F11R-targeted shRNA.
We confirmed that shRNA was delivered to the heart (Figure S13,
Supporting Information), in addition to other major visceral or-
gans (Supplement S3, Supporting Information). We also verified
the expressions of PGRMC2 and F11R. Based on the shRNA dis-
tribution, we designed our approach to include a complete eval-
uation of the cELV effect on these organs, especially to that of the
cardiovascular function.
Four weeks after the PGRMC2-targeted shRNA silencing, half
of the mice died from cardiovascular collapse because of low
blood pressure (Figure 6b). Compared with scrambled control
mice, the systolic and diastolic blood pressures in PGRMC2 and
F11R mice were significantly lower (Figure 6c,d). The mean ar-
terial pressure was also lower in PGRMC2 and F11R mice com-
pared with control mice but the heart rate was similar to that of
control mice (Figure 6e,f). There were no apparent changes in
body weight in both PGRMC2 and F11R mice (Figure 6g). Fur-
ther analyses confirmed that cELV was not present in PGRMC2
or F11R mice (Figure 6h). Importantly, circulating vesicles (or
cELV) collected from the blood serum were significantly re-
pressed in PGRMC2 or F11R mice (Figure 6i). Our in vivo data
were consistent with our in vitro measurement showing de-
creased cELV and its release in PGRMC2 or F11R cells. Extracar-
diac phenotypes were also observed (Supplement S3 and Movie
S13, Supporting Information).
2.6. Mice Lacking cELV Have Arrhythmogenic Hearts
Characterized with Compensated Left Ventricle Function and
Cardiac Fibrosis
To quantify cardiac performance, we measured cardiac param-
eters independent of the neuronal responses using the ex vivo
isolated working heart system (Movie S14, Supporting Informa-
tion). Abnormal rhythmic pacing was seen after the heart rate
Figure 2. Selected cELV proteins are expressed in subdomain of primary cilia. Selected proteins (red) were localized to cELV. Acetylated 𝛼-tubulin (green)
and DAPI (blue) were used as ciliary and nuclear markers. High-resolution differential interference contrast (DIC) images confirmed the presence of
cilia. Actin was used as a negative control. Ciliary marker acetylated-𝛼-tubulin = acet-𝛼-tubulin.
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Figure 3. Selected cELV proteins are involved in cELV formation and suppression of TMEM216 expression. a) A representative DIC images showing all
corresponding knockdown genes impact on cilia and/or cELV formation. b,c) The effects of cELV proteins on cilia formation and cELV formation were
quantified in BMPR2, TFRC, F11R, PTPRS and PGRMC2 knockdown cells. d) The averaged cilium length is shown in the bar graph. The effect of the
knockdown on ciliary length distributions is shown in the histogram (Figure S6d, Supporting Information). N = 3 with 40 measurements for each N.
For the cELV measurements, total cELV from replicates are shown because most cilia did not have cELV. e) A network of protein–protein interactions
analyzed from the proteomic studies shows the functional interface of the five selected cELV proteins (highlighted in yellow) with TMEM216 (highlighted
in blue) and known EV marker proteins (bolded red boarder). Dotted blue lines represent an interaction with the selected ciliary proteins or TMEM216.
f,g) A quantitative Western blot analysis of TMEM216 expression was performed in PGRMC2 or F11R knockdown cells. N = 5 for Western blot. h) The
cELV secretion was quantified in PGRMC2 or F11R knockdown cells. N = 3 for cELV quantification. *, p < 0.05; **, p < 0.01; ***, p < 0.001; compared
with the scrambled control.
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Figure 4. Repressed cELV protein expression results in ciliopathy phenotypes, pericardiac edema, and randomized heart position in zebrafish. a) Fish
were injected with scrambled, specific F11R or PGRMC2 mRNA, morpholino (MO), and both mRNA plus morpholino. Representative phase contrast
images show zebrafish at 48 and 72 h postfertilization (hpf). The H&E images represent fish at 72-hpf; black and red asterisks indicate hydrocephalus
and renal cysts, respectively. nc = notochord. b) In addition to pericardiac edema (Figure S12, Supporting Information), randomized heart looping was
observed in PGRMC2 MO fish (Movie S9, Supporting Information) Yellow- and green-dotted circles show ventricle and bulbus arteriosus, respectively.
c) Confirmation of the rescue phenotype was confirmed with the corresponding protein expression via Western blot analysis. d) A quantitative analysis
of asymmetry, kidney cysts and hydrocephalus depict the frequency and severity of the phenotypes. N = 40–60 fish per group. *, p < 0.05; **, p < 0.01;
compared with the scrambled control.
was slowed down with verapamil from 143 ± 12 to 91 ± 9 beats
per minute (Figure 7a), indicating that the hearts from PGRMC2
and F11R mice could have been sustained with prolonged sympa-
thetic stimulation. Further analyses of cardiac functions showed
that the left ventricular volume was decreased while the left ven-
tricular pressure increased in the hearts of PGRMC2 and F11R
knockdown mice (Figure 7b). When complete left ventricle pa-
rameters were measured (Table S3, Supporting Information), the
overall left ventricle functions except stroke work were signifi-
cantly lowered (Figure 7c). Because there was no change in heart
rate, a decreased in cardiac output of PGRMC2 and F11R hearts
was primarily derived from a repressed in stroke volume. De-
creased in ejection fraction was an indication of failing PGRMC2
and F11R hearts. Consistent with this idea, hearts stimulation
with epinephrine tended to correct ventricular functions compa-
rable to the scrambled control.
The thickness of the left ventricle of PGRMC2 and F11R hearts
was compared in transverse cut of whole mount hearts (Fig-
ure 8a). Left ventricle hypertrophy was also apparent in these
mice. Cardiac morphology was further analyzed with standard
H&E and Masson’s Trichrome staining (Figure 8b). The staining
showed left and right ventricles with significant fibrosis in the left
ventricular endocardial regions of hearts from the PGRMC2 and
F11R knockdown mice. While the hearts had significant hyper-
trophy, the mass of the heart and heart-to-body mass ratio were
not significantly different in F11R or PGRMC2 mice compared
with scrambled control mice (Figure 8c). Together with left ven-
tricular hypertrophy, such a cardiac phenotype potentially indi-
cated aortic stenosis. As a result, the overall stroke volume and
cardiac output are significantly decreased in mice lacking cELV.
3. Discussion
Our studies indicate that the ciliary extracellular-like vesicle
(cELV) and primary cilium influence the dynamic characteristics
of each other. First, the cELV increases the flexural rigidity of
cilia, likely due to an increase of protein transport from cell body
to cilia. Consistently, blocking the cELV formation decreases
ciliary mass and results in structurally less rigid primary cilia.
Second, the bending of cilia changes the dynamic shape of the
cELV (roundness, including circumference, and circularity) and
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Figure 5. Repressing cELV protein expression affects the cardiac functions in zebrafish. Cardiac parameters were measured in all selected cELV proteins
(Figure S12 and Movie S11, Supporting Information). a) cardiac contractility and heart rate were measured in fish injected with scrambled, specific F11R
or PGRMC2 mRNA, morpholino (MO), and both mRNA plus morpholino over a 20 s period (Movie S12, Supporting Information). b) The parameters
of cardiac functions were quantified. N = 40–60 fish per group. *, p < 0.05; ****, p < 0.0001; compared with the scrambled control.
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allows the cELV to reposition to the tip of the cilium in response
to fluid-shear stress. This further indicates that cELV is not
anchored to the ciliary axoneme and its movement along ciliary
exoneme is regulated by the microenvironments surrounding
the cell. Although tips of cilia can be excised through a process
that is cell-cycle dependent,[26] surprisingly bending of a cilium
by fluid-shear stress is also sufficient to release the cELV. Third,
the mass of the cELV is directly proportional to the mass of
cilium.
To ensure that the cELV is not extracellular debris adhering
onto the cilium, we have used different approaches to validate
cELV is indeed generated from the cilia. First, unlike extracel-
lular debris with random behaviors and patterns, the dynamic
movements and characteristics of cELV along the cilia are mathe-
matically not random. The cELV have predictable patterns (Movie
S1 and Figure S1a–c, Supporting Information). Second, we have
tagged the cEVL with known biomarker (CD63-GFP) to selec-
tively study and trace the movements of these vesicles every 12–
24 h. CD63-GFP is expressed throughout the cell body and cilia
in the first 24 h post-transfection and specifically in the cELV
at 72 h post-transfection (Figure 1a; Figure S2c, Supporting In-
formation). Third, the cELV containing CD63-GFP is uniquely
localized to cilia. We never observe non-GFP cELV in the cilia
in cells expressing CD63-GFP. The release of cELV from the
primary cilium can also be observed (Movie S4, Supporting In-
formation). Forth, when the cELV formation is inhibited, num-
bers of cilia with cELV are significantly decreased (Figure 3a,c).
Fifth, the cELV formation can be induced by mechanical shear-
stress. Compared to static (no-flow) condition where only 31% of
cilia have cELV, shear-flow induces cELV formation in over 85%
of cilia (Movie S8, Supporting Information).[42] Sixth, previous
electron microscopy study shows that cELV is integrated within
cilioplasm.[49]
Given that various proteins, RNAs, microRNAs, and even
DNA materials have been found in common extracellular vesi-
cle (EV),[50–52] it opens the possibility that those contents could
also be found in cELV. Further, this possibility could provide new
functions of proteins or nucleotides within cilia that were once
thought to be present only in the cytosol, as shown by this study
that cytosolic EV proteins or markers can also be found in cELV.
However, whether cELV can be assembled within the cilioplasm
still remains unknown. Differentiating the origin of the cELV
(cilia vs cytosolic) remains a challenge, because most known cy-
tosolic EV markers are also found in the proteome of the cELV.
However, we can differentiate cELV from other EV based on their
release and signaling characteristics. To our advantage, since the
cELV is induced by fluid-shear stress[42] and isolation of primary
cilia is different from that of cytosolic EV, we isolated cilia con-
taining cELV to avoid EV from the cell body. This enables us to
distinguishably identify a list of a unique cELV protein composi-
tion by using differential proteomic analyses (Table S2, Support-
ing Information).
Validating five proteins (BMPR2, TfR1, JAM-A, PTPRS, and
PGRMC2) from the proteomic list show that these proteins are
part of ciliary proteins, particularly localized in the cELV. It is very
possible that not all proteins in our list localize in the cELV, as
some proteins might be more specific to ciliary axonemes. How-
ever, due to the way in which we isolated the primary cilia, we hy-
pothesize that the turnout of cELV proteins should be very high.
It is also worth to note that many proteins in the list interact with
each other and only few proteins interact with TMEM216, a pro-
tein involved in cilia formation.[3–5] The biochemistry studies on
the knockdown cells of all five genes show that some of them
affected ciliogenesis, while all five knockdown cells show a sig-
nificant impediment in cELV formation in addition to abnormal
migration for wound closure. Importantly, knockdown of any of
those five cELV protein significantly decreases release of cELV to
the media. We thus speculate that the cell–cell communication
process through primary cilia and cELV may be crucial in main-
taining cellular function. The knockdown of cELV proteins can
significantly interrupt the biogenesis of cELV and thus cellular
function of many organs, including heart. In addition, the sig-
nificant increase of cell proliferation index due to repressing the
expression of cELV protein is indicative of the roles of cELV in
cellular functions.
For the first time, we show that PGRMC2 and F11R mice
have cardiac arrhythmogenic defect characterized with a signif-
icant low ejection fraction (Table S3, Supporting Information).
The left ventricular volume is decreased with augmented pres-
sure in the hearts of mice lacking cELV. Both ejection frac-
tion and cardiac output are decreased, and these characteris-
tics are disappeared when challenged with epinephrine. Be-
cause arrhythmia is observed when the heart rate is decreased,
the overall cardiac function could thus have been sustained
via sympathetic stimulation. Together with left ventricular hy-
pertrophy, such a cardiac phenotype indicates aortic stenosis,
a cardiac abnormality commonly seen in patients with Joubert
syndrome.[53] Of note is that many cELV proteins directly or indi-
rectly interacted with each other and TMEM216, a gene respon-
sible for Joubert syndrome and Meckel–Gruber syndrome cil-
iopathy disorders.[3–5] The aortic stenosis may thus explain the
drop in blood pressure.[54,55] Overall, we here provide the first
plausible explanation for primary cilia as antennae for cell–cell
communication.
Repressing cELV protein expression in zebrafish animal model
results in syndromic ciliopathy disorders and abnormal cardio-
vascular functions, including cystic kidney, hydrocephalus, ran-
domized heart looping, pericardial edema, and abnormal car-
diac functions. The regulation of TMEM216 expression by F11R
and PGRMC2 may partially explain the ciliopathy phenotypes
seen in zebrafish model. However, we believe that the lacking
of cELV has a predominant effect on the abnormal cardiac func-
tions through the disruption of endocrine signaling mediators via
cell–cell communication. Losing this signaling mechanism can
Figure 6. Mice lacking of cELV are hypotensive. a) Schematic timeline shows overall study approach in mice. Lentivirus was injected subcutaneously
(SQ) into 2 week old mice. b) The survival curve shows that the PGRMC2 knockdown mice had a significantly higher mortality rate. Systolic (SBP, c),
diastolic (DBP, d) blood pressure, mean arterial pressure (MAP, e), heart rate (HR, f) and body weight (g) were recorded from 6 8, and 10 week old (w.o.)
mice after 1 week of acclimation. h) Representative electron micrographs indicate PGRMC2 and F11R knockdown mice lacked of cELV. Arrow indicates
cELV in scrambled control mouse. i) Circulating cELVs were quantified by collecting serum of the mice at the end point of the study. N = 8–12 mice for
the scrambled control, PGRMC2 and F11R knockdown groups. *, p < 0.05; **, p < 0.01; compared with the scrambled control.
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Figure 7. Mice lacking of cELV have arrhythmogenic heart with compensated left ventricle function. a) Measurements of heart electrical signal were per-
formed using electrocardiograms in isolated hearts. Stress tests were performed with negative (verapamil; VA) or positive (epinephrine; Epi) chronotropic
agents. Arrows indicate abnormal pacing. b) The relationship between the left ventricular pressure (LVP) and left ventricular volume (LVV) was analyzed
as an index of heart function. c) Heart rate (bpm, beat per minute) and left ventricle functions were analyzed from the isolated working heart. A complete
set of parameters for left ventricle function is shown in Table S3 (Supporting Information). N = 4 in each working heart analysis group. *, p < 0.05; **,
p < 0.01; ***, p < 0.001; compared with the corresponding scrambled-saline group.
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Figure 8. Mice lacking of cELVs have left ventricular hypertrophy and cardiac fibrosis. a) The thickness of the left ventricle was compared in transverse
cut of whole mount hearts, showing left ventricular hypertrophy in PGRMC2 and F11R mice. b) Representative images of H&E and Masson’s Trichrome
staining show left and right ventricles with significant fibrosis in the left ventricular endocardial regions of hearts from the PGRMC2 and F11R knockdown
mice. c) Left ventricular thickness, heart weight, heart-to-body weight ratio and percent of fibrosis in the heart were quantified. N = 3 mice in each
scrambled control, PGRMC2 and F11R knockdown groups. *, p < 0.05; ***, p < 0.001; compared with the corresponding scrambled control group.
prevent myocardial cells from transferring crucial proteins,
miRNA and DNA from one cell to another. This cellular mech-
anism of cELVs is also observed in the mouse animal mod-
els, where low circulating cELVs affect the blood pressure, heart
rhythm, left ventricle function, and myocardial morphology.
While the role of cELVs is not known, microvesicles have been
proposed to function as a secured and protected cell–cell com-
munication device within the cardiovascular system.[30–33] In ad-
dition, cELVs are involved in Ca2+ and cAMP signaling (Figures
S3–S7, Supporting Information). These second messengers are
known to regulate contractility in the heart.[56–58] All in all, we
propose a cellular mechanism of primary cilia as follow: primary
cilia (Figures 1 and 2) → cELVs (Figures 2 and 3) → endocrine
signaling (Figures 4 and 5) → Ca2+ and cAMP signaling (Fig-
ures S3–S7, Supporting Information)→ cardiovascular functions
(Figures 6–8). Similar to the emerging evidence of extracellular
vesicles as biomarkers,[59–61] our results support that cELVs could
potentially be used as a biomarker for cardiovascular and cilia-
related diseases.
In summary, we show that cELV is regulated and releasable by
mechanical fluid force. We also report characteristics and impact
of cELV on the cardiovascular system. Importantly, we have iden-
tified a novel protein composition of cELV by using differential
proteomic analyses. Our results reveal that cELV plays a unique
role in ciliary signaling, cellular functions, and maintaining car-
diovascular homeostasis.
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